How Much Weight Are People Losing on Wegovy?

Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy (semaglutide) has become one of the most popular weight loss medications in the United States, with clinical trials showing participants lose an average of 15 pounds per month during the first few months of treatment. However, many people are unaware that compounded versions of semaglutide deliver identical therapeutic benefits at a fraction of the cost. PlexusDx provides access to pharmacy-compounded semaglutide injections from licensed 503A facilities, allowing patients to achieve comparable weight loss outcomes without the premium brand markup.

Clinical Trial Data on Semaglutide Weight Loss

The STEP trials, which tested semaglutide efficacy, demonstrated that patients on the highest maintenance dose (2.4 mg weekly) lost an average of 15.3 kg (approximately 34 pounds) over 68 weeks—representing about 17.4% of baseline body weight. In comparison, the placebo group lost only 2.6 kg. These results underscore semaglutide's mechanism: it slows gastric emptying, reduces appetite-related hormone signaling, and increases feelings of fullness, allowing sustained caloric restriction without severe hunger.

The PlexusDx Precision Peptide Genetic Test analyzes FTO — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Wegovy vs. Compounded Semaglutide: What's the Difference?

Wegovy and compounded semaglutide contain the identical active pharmaceutical ingredient (semaglutide) manufactured to the same purity and potency standards. The primary differences are regulatory pathway, supply chain, and price. Wegovy carries FDA approval as a branded pharmaceutical, while compounded semaglutide is prepared by licensed 503A compounding pharmacies under USP <797> standards. Both forms undergo rigorous quality assurance testing, and efficacy data shows no meaningful clinical difference between the two.

The cost advantage of compounded semaglutide is substantial. Wegovy typically costs $900-$1,300 per month without insurance coverage, whereas PlexusDx's compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan. This 75-85% price reduction allows more patients to access treatment long-term without financial burden. Because your dose may need to go up as your body adapts, your price won't—PlexusDx maintains flat monthly pricing across all dose adjustments and commitment tiers.

Average Weight Loss Timeline on Semaglutide

Most patients experience noticeable weight loss within 4-8 weeks of starting semaglutide therapy, though the dose-titration schedule (which increases every 4 weeks to minimize side effects) means maximum efficacy often takes 16-20 weeks to achieve. During the initial phase, patients frequently report a 5-10 pound loss, largely driven by reduced food intake and appetite suppression. As the body adapts and the dose reaches therapeutic levels, weekly weight loss typically stabilizes between 0.5-2 pounds, compounding into significant long-term results.

Plateau periods are common and expected—the body's weight-regulation systems eventually adapt to lower caloric intake and medication effects. Many patients experience renewed weight loss after adjusting calorie intake, increasing physical activity, or (in some cases) increasing the semaglutide dose under medical supervision. Sustained weight loss at 1-year follow-up averages 12-18% of baseline body weight among those who remain consistent with treatment and lifestyle modifications.

Factors That Influence Your Personal Weight Loss Results

Genetic predisposition plays a measurable role in semaglutide response. The FTO gene (fat mass and obesity-associated) variant rs9939609 affects how your body regulates energy expenditure and appetite—individuals with certain FTO variants may require higher doses or longer treatment durations to achieve target weight loss. Similarly, the GLP1R gene variant rs6923761 influences how your receptors respond to semaglutide signaling. The Precision Peptide Genetic Test identifies these and 48 other peptide-pathway variants, giving you personalized insights into your predicted treatment response before committing to therapy.

Beyond genetics, age, baseline metabolic rate, insulin resistance, underlying medications, and adherence to caloric reduction all impact results. Patients who combine semaglutide with structured nutrition counseling and regular physical activity typically achieve 5-10% greater weight loss than those relying on medication alone. Sleep quality, stress levels, and thyroid function also modulate GLP-1 pathway activity. PlexusDx's personalized approach accounts for these variables, helping you optimize your treatment plan for maximum sustainable results.

Getting Started With PlexusDx Semaglutide

PlexusDx serves all 50 states without requiring insurance, membership fees, or prior insurance authorization. The process begins with a brief online health assessment and physician consultation to confirm semaglutide safety and eligibility. Compounded semaglutide injections are prepared at licensed 503A pharmacies and shipped directly to your home with full injection instructions and support. Pricing is $189/mo month-to-month, or from $149/mo on the 6-month plan—your dose may go up as treatment progresses, but your price remains flat across all commitment tiers.

For patients seeking deeper insight into their genetic predisposition to weight loss medication response, PlexusDx offers the Precision Peptide Genetic Test for $298. This test maps 14 appetite-regulation and metabolic pathways, providing actionable insights about your semaglutide response likelihood and optimal dosing strategy. Combined with regular follow-ups and dose adjustments guided by clinical protocols, this personalized approach maximizes your chances of achieving meaningful, sustained weight loss.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight does the average person lose on Wegovy or semaglutide?

Clinical trials show average weight loss of 15-22% of baseline body weight over 68 weeks on semaglutide 2.4 mg weekly. Individual results vary: some patients lose 1-2 pounds per week initially, while others experience slower, steadier losses of 0.5 pounds weekly. Factors like genetics, diet adherence, and baseline metabolism influence personal outcomes.

Why is compounded semaglutide cheaper than brand-name Wegovy?

Both contain identical semaglutide prepared to the same purity standards by licensed 503A pharmacies. The cost difference reflects brand premium, marketing, and regulatory pathway rather than ingredient or efficacy. PlexusDx passes these savings to patients, offering semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan versus $900-$1,300 for Wegovy.

Can PlexusDx semaglutide work as well as Wegovy?

Yes. Compounded and brand-name semaglutide have identical active ingredients and clinical efficacy. Both are prepared to pharmaceutical purity standards and undergo rigorous quality assurance. The only meaningful difference is cost—your dose may increase, but your price won't at PlexusDx.

What if semaglutide doesn't work for me?

Some patients respond better to tirzepatide, a dual GLP-1/GIP receptor agonist that may produce greater weight loss in certain populations. PlexusDx offers compounded tirzepatide injections at $289/mo month-to-month, or from $249/mo on the 6-month plan, as well as combination therapies like GLP-Squared (semaglutide + tirzepatide) if single-agent therapy plateaus. Your doctor can help determine the best adjustment based on your response.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The test identifies genetic variants in 14 metabolic and appetite-regulation pathways, including FTO, GIPR, and MC4R genes. These variants influence how efficiently your body responds to semaglutide and your baseline weight regulation. Understanding your genetic predisposition helps your physician optimize dosing and identify if an alternative medication (like tirzepatide) might suit you better—available for $298.

Related Reading

• Wegovy For Losing Weight
• Glp 1 For Losing Weight
• Zepbound For Losing Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.